Metraipolis › archive › dc_47e696df5018

Darolutamide-based triple therapy combined with PSMA imaging guided focal treatment in patients with prostate cancer: a multicenter retrospective study — Europe PMC PMID:41415573

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41415573
DOI
10.3389/fphar.2025.1692407
License (as archived)
solo-consultazione
Archived
2026-11-07T23:47:21.403Z
SHA-256 of the archived text
bbe7209e9eca0146d9aa82f3983d78dca465fa88fe643b85a14ab1fceb4dc086
Stable URL of this page
https://metraipolis.com/documento/dc_47e696df5018

How to cite

Darolutamide-based triple therapy combined with PSMA imaging guided focal treatment in patients with prostate cancer: a multicenter retrospective study — Europe PMC PMID:41415573 — Europe PMC (en), https://europepmc.org/article/MED/41415573 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_47e696df5018 (Metraipolis archive dc_47e696df5018, sha256 bbe7209e9eca0146d9aa82f3983d78dca465fa88fe643b85a14ab1fceb4dc086)
BibTeX
@misc{dc47e696df5018,
  title = {Darolutamide-based triple therapy combined with PSMA imaging guided focal treatment in patients with prostate cancer: a multicenter retrospective study — Europe PMC PMID:41415573},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41415573},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_47e696df5018; sha256 bbe7209e9eca0146d9aa82f3983d78dca465fa88fe643b85a14ab1fceb4dc086},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41415573. Agents can read the archived copy with the MCP tool read_document.